LS&HC Horizons 2022 - Flipbook - Page 51
8
Asia-Pacific
Chinese anti-monopoly issues when settling patent
invalidation actions
52
Use of Real-World Evidence for the registration
of medical devices and drugs in China
53
China’s combat on medical insurance fraud
54
Life sciences in Japan
55
Conducting life science investigations in India
56
